US FDA launches AI tool to reduce time taken for scientific reviews
Bengaluru: The U.S. Food and Drug Administration said on Monday that it had launched a generative
AI tool
,
Elsa
, aimed at improving efficiency across its operations, including
scientific reviews
.
"Today's rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers," said FDA Commissioner Marty Makary.
The agency said it is already using Elsa to expedite
clinical protocol reviews
, shorten the time needed for scientific evaluations, and pinpoint high-priority inspection targets.
Once the FDA receives an application for a potential
drug approval
, it has six to 10 months to make a decision.
Elsa assists with reading, writing, and summarizing tasks. It can summarize adverse events to support safety profile assessments of drugs and rapidly compare packaging inserts.
"Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff," the FDA said.
In May, the regulator said it would fully integrate AI by June 30, following an experimental run.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
U.S. Senate debates whether to adopt revised state AI regulation ban
Two key U.S. Republican senators agreed to a revised federal moratorium on state regulation of artificial intelligence to five years and allow states to adopt rules on child online safety and protecting artists' image or likeliness. Senate Commerce Committee chair Ted Cruz originally proposed securing compliance by blocking states that regulate AI from a $42 billion broadband infrastructure fund as part of a broad tax and budget bill. A revised version released last week would only restrict states regulating AI form tapping a new $500 million fund to support AI infrastructure. Under a compromise announced Sunday by Senator Marsha Blackburn, a critic of the state AI regulatory moratorium, the proposed 10-year moratorium would be cut to five years and allow states to regulate issues like protecting artists' voices or child online safety if they do not impose an "undue or disproportionate burden" on AI. Tennessee passed a law last year dubbed the ELVIS Act to protect songwriters and performers from the use of AI to make unauthorised fake works in the image and voice of well-known artists. Texas approved legislation to bar AI use for the creation of child pornography or to encourage a person to commit physical self-harm or commit crime. It is not clear if the change will be enough to assuage concerns. On Friday, 17 Republican governors urged the Senate to drop the AI plan. "We cannot support a provision that takes away states' powers to protect our citizens. Let states function as the laboratories of democracy they were intended to be and allow state leaders to protect our people," said the governors led by Arkansas' Sarah Huckabee Sanders. U.S. Commerce Secretary Howard Lutnick voiced his support for the revised measure calling it a pragmatic compromise. "Congress should stand by the Cruz provision to keep America First in AI," Lutnick wrote on X. Congress has failed for years to pass any meaningful AI regulations or safety measures. Senate Maria Cantwell, the top Democrat on the Commerce Committee, said the Blackburn Cruz amendment "does nothing to protect kids or consumers. It's just another giveaway to tech companies." Cantwell said Lutnick could simply opt to strip states of internet funding if they did not agree to the moratorium.
NDTV
an hour ago
- NDTV
Shefali Jariwala Death Puts The Spotlight On How Youth Is The New Status Symbol
In the 1890s, renowned Irish author, poet, and playwright Oscar Wilde published his novel The Picture of Dorian Gray. The story revolves around a handsome but narcissistic man named Dorian Gray, who barters his soul to preserve his youthful appearance. While he remains outwardly beautiful, his inner self becomes increasingly corrupted by vanity and hedonism. The decay of his soul is revealed only in a painted portrait that reflects the consequences of his actions. Cut to almost five decades later, the book still remains relevant and raises a question that continues to haunt us. How far are you willing to go to look a certain way? Oscar Wilde's novel might have painted a dystopian world for his time, but today, it feels like we're living it. Youth, looking young, having a baby face, and ageing slowly seems to be the latest obsession for the elite, and there's no stopping it. Now, we're not saying that taking care of yourself is bad, but when it turns into an obsession like Dorian's, we might end up like him: dead. How Youth Is Becoming The Ultimate Status Symbol The death of actor-model Shefali Jariwala on June 27 has raised several questions. According to sources, one possible cause of her heart attack could be anti-ageing injections like glutathione and Vitamin C, which she may have taken while fasting - causing a drop in her blood pressure and leading to cardiac arrest. These drugs are neither FDA- nor Central Drugs Standard Control Organisation-approved for skin whitening, brightening or anti-ageing. Shefali's death has once again spotlighted the harsh beauty standards women are held against. In the 21st century, beauty doesn't lie in the eyes of the beholder - it lies in the hands of doctors. Biohacking. Supplements. Anti-ageing drugs. These terms have gained momentum over the past few years. Looking and feeling young is becoming the ultimate status symbol. From Kris Jenner getting a new face at 69 to Bryan Johnson, the infamous millionaire-turned-biohacker who does everything to reverse his biological age -- celebs' and social media influencers' obsession of looking young has led to a booming anti-ageing market. Data shows the anti-ageing market reached USD 122 billion in 2023 and is only expected to grow. This enormous market often influences people, especially women, to hold themselves to unrealistic beauty standards. Today, a 14-year-old starting anti-ageing treatments with retinol, documenting it all on social media, no longer surprises anyone. This trend has led to a phenomenon where Gen Zs are starting to look older than they actually are. But Why? These beauty standards and the need to look young are so normalised and ingrained in our brains that we rarely pause to ask the ultimate question -- why is looking and feeling 'young' so important? Neuroscientist Kumaar Bagrodia, founder of NeuroLeap and HALE, tells NDTV that in the modern brain, youth equals currency. "Neuroscience shows that youthful faces trigger key reward circuits -- like the ventral tegmental area and nucleus accumbens -- the same circuits activated by money, attention, and social validation," Bagrodia explains. He adds that the Default Mode Network (DMN), responsible for how we see ourselves and compare ourselves to others, is constantly processing social cues. In today's world, visual markers of youth signal power, vitality, and relevance. They tell everyone that we still belong. In parallel, the Salience Network (a collection of brain regions that helps identify and prioritise stimuli) tunes our attention to what society rewards. When filtered beauty, botox, and anti-ageing hacks dominate media feeds, the brain adapts and prioritises youth as a survival asset. "Looking young isn't just an aesthetic; it's a neuro-status signal. And in today's attention economy, youth wins the algorithm, the approval, and the influence," he adds. This obsession with looking young has not only created a multi-billion dollar market but has also led to a rise in anti-ageing treatments that, if not performed under expert supervision, can seriously harm your health, or even prove fatal. The Rise In Anti-Ageing Treatments NDTV spoke to various experts who all agreed that there's been a notable rise in anti-ageing treatments. "There has undoubtedly been a visible rise in demand for anti-ageing treatments. I have increasing numbers of patients seeking preventive dermatology, injectables like botox and fillers, and non-surgical procedures like lasers and RF therapy. Social media, increased awareness, and a desire to age well are strong driving factors," says Dr Chandani Jain Gupta, MBBS, MD, Dermatologist & Aesthetic Physician at Elantis Healthcare, New Delhi. Dr Ajay Rana, Dermatologist and Aesthetic Physician and Founder & Director of ILAMED, says this shift is part of a wider trend, "With advancements in cosmetic dermatology and a growing awareness of skin health, more people are turning to these treatments to address signs of ageing and maintain a youthful appearance." Dr Shweta Tripathi, Senior Consultant Dermatologist and Aesthetic Injector and Founder of My Skindom Skin Clinic, adds, "Everybody wants to look a certain way. Looking young is now accessible at your doorstep. People are extremely conscious about their fine lines and folds." According to experts, millennials and Gen Zs are increasingly starting preventive care early. Common treatments include: Botox, dermal fillers, chemical peels, laser resurfacing, PRP, and skin boosters Non-invasive options like HIFU (High-Intensity Focused Ultrasound) and Thermage for minimal downtime 'If Not Done Right, Anti-Ageing Can Go Dangerously Wrong' Dr Mahnaz Jahan Begum, Aesthetic Expert, Entrepreneur, Founder of Keradis and Medical Director at Aterm Clinics, Kolkata, says, "Anti-ageing therapies should always be tailored, monitored, and based on thorough diagnostics. What works for one body could be dangerous for another-especially if there are hidden heart issues." She highlights risks often ignored in casual or unmonitored settings: Hormone therapies like HRT or testosterone carry risks of heart attack, stroke, and blood clotting NAD+ infusions, growth hormone boosters, and metabolic enhancers can raise blood pressure and affect heart rhythm Stimulants for fat loss or energy can increase the risk of sudden cardiac events Dr Chandani Jain Gupta reiterates, "If anti-ageing treatments are not done correctly or by inexperienced hands, they can lead to serious complications like infection, scarring, or abnormal results." Dr Tripathi explains, "Injectables work on muscles and some fillers can migrate. If not done correctly, they can cause permanent damage." Dr Rana adds, "Poorly administered treatments may result in allergic reactions or unsatisfactory results. These are not quick-fix beauty hacks-they require clinical knowledge and precision." Biohacking: A Dangerous Influence On Younger Adults The recent explosion in biohacking trends; yet another anti-ageing treatment largely influenced by online content and celebrity wellness endorsements (read Bryan Johnson), has sparked concern. Today, the biohacking market is expected to reach USD 149.6 billion between 2025 and 2029, significantly impacting millennials and Gen Z, and their drive to look younger. View this post on Instagram A post shared by Bryan Johnson (@bryanjohnson_) Dr Begum describes biohacking as "a movement where people use science, supplements, wearables, and even prescription drugs to 'optimise' their bodies and slow ageing". But she warns that "there's a dangerous misconception that anything 'natural' or 'anti-ageing' is automatically safe". Dr Gupta notes that unsupervised biohacking carries several risks, including: Hormonal imbalances Nutrient depletion Sleep disruption "Anti-ageing treatments are no longer just about reversing time; they're about enhancing confidence, maintaining skin health, and ageing gracefully. But one must always follow pre- and post-care protocols for safe, long-lasting results," Dr Shikha Baghi, BDS, MDS, Founder and MD, Timeless Aesthetics, reminds us of the bigger picture as she concludes. The Fine Line The line between self-care and obsession is growing thinner, blurred by filters, pressure, and pseudo-science. While science continues to evolve and offer incredible ways to age gracefully, the cost of blindly following trends can be more than skin deep.
Economic Times
2 hours ago
- Economic Times
Stocks in news: Federal Bank, Apollo Hospitals, JK Cement, HCL Tech, Bharat Forge
Markets experienced a slight dip after a recent surge, with several companies making headlines. Apollo Hospitals is set for a restructuring, while Kalpataru Projects secured new orders. Federal Bank approved fundraising plans, and Hindustan Copper signed an MoU with Coal India for mineral exploration. Additionally, HCLTech announced a collaboration with OpenAI to boost AI adoption. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Markets began the week on a soft note, slipping nearly half a percent as they took a breather following the recent surge. In today's trade, shares of Federal Bank Bharat Forge among others will be in focus due to various news Hospitals plans major restructuring, approved the demerger, mergers and new listing of Apollo Projects announced securing new orders worth Rs 989 crore in the power transmission and distribution (T&D) arm Green Energy has begun commercial electricity supply of an additional 100.02 MW from its 1,000 MW solar power project at Bikaner in Rajasthan from Bank board approved fundraising plans through equity and debt instruments up to Rs 6,000 croreCG Power opened its qualified institutional placement (QIP), indicative total issue size at Rs 3,000 crore, according to Copper signed an MoU with Coal India for Copper, critical minerals Forge board approved the defence business transfer to Kalyani Strategic Systems arm via Optionally Convertible Redeemable Preference Shares (OCRPs) for Rs 500 croreESAF Small Finance Bank transfered its NPA and technically written-off loans worth Rs 733 crore to an ARC for Rs 73.34 Industries raised its take in arm Godrej Capital to 90.89% from 89.48%with an investment of Rs 285 Minda completed the acquisition of 1.69 crore shares (49.90% stake) of UnoMinda EV Systems from FRIWO GmbH for Rs 141.27 and OpenAI announced collaboration to accelerate enterprise-scale AI adoption.S Mahesh Babu resigned as the CEO of Switch Automotive Mobility with effect from August 31. Ganesh Mani takes additional Cement declared a final dividend of Rs 15 per share for Fin Homes appointed Abhishek Mishra as CFO for three years with effect from June 30.
